My Cart [ 0 ]
Home > Proteins & Peptides > A-Z Proteins  > Biotinylated Human VEGF R2 Protein

Biotinylated Human VEGF R2 Protein

CD309; KDR; VEGFR; VEGFR2; VEGFR-21; FLK1; KRD1; Ly73

Catalog No. Product Name Size List Price (US$) Quantity
BP003701 Biotinylated Human VEGF R2/KDR Protein with the C-mFc Tag 100 ug 525.00
BP003701 Biotinylated Human VEGF R2/KDR Protein with the C-mFc Tag 500 ug 1750.00
BP004956 Biotinylated Human VEGF R2/KDR Protein with the C-His-Avi Tag 100 ug 525.00
BP004956 Biotinylated Human VEGF R2/KDR Protein with the C-His-Avi Tag 500 ug 1750.00
Description

BP003701: Biotinylated Human VEGF R2/KDR Protein with the C-mFc Tag

Source: The recombinant Biotinylated Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Biotinylated Human VEGF R2/KDR protein with the mFc tag at the C-terminus has a predicted MW of 110 kDa. Due to glycosylation, the protein migrates to 135-160 kDa based on Bis-Tris PAGE result.
Activity: Immobilized recombinant Human VEGF165 protein with the C-mFc tag at 5 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Human VEGF R2 protein with the C-mFc tag with the EC50 of 98.8 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Biotinylated Human VEGF R2/KDR Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.

BP004956: Biotinylated Human VEGF R2/KDR Protein with the C-His-Avi Tag

Source: The recombinant Biotinylated Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight: The recombinant Biotinylated Human VEGF R2/KDR protein with the His-Avi tag at the C-terminus has a predicted MW of 86.2 kDa. Due to glycosylation, the protein migrates to 115-140 kDa based on Bis-Tris PAGE result.
Activity: Immobilized recombinant Biotinylated Human VEGF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-VEGF R2 Antibody protein with the C-hFc tag with the EC50 of 8.2 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution: It is recommended to reconstitute the lyophilized recombinant Biotinylated Human VEGF R2/KDR Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening.


Shipping: The recombinant Biotinylated Human VEGF R2/KDR Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 week, 2 to 8°C under sterile conditions after reconstitution.
6 months, -20 to -70°C under sterile conditions after reconstitution.

Related Links

See our Privacy Policy